Searchable abstracts of presentations at key conferences in endocrinology

ea0067gp14 | Poster Presentations | EYES2019

Takotsubo cardiomyopathy: always exclude pheochromocytoma

Gyftaki R , Klogeris N , Dalakoura S , Cherolidi E , Aggelaki M , Bourboulis N , Vryonidou A

Background: Pheochromocytomas are catecholamine-producing neuroendocrine tumors, arising from the adrenal medulla or from paraganglionic chromafin tissue. Their clinical presentation, mainly attributable to the increased catecholamine production and it is highly variable. We herein present a case of a 42-year-old female patient with recurrent episodes of Takotsubo cardiomyopathy due to a pheochromocytoma.Case presentation: The patient presented two years...

ea0037s11.1 | Hot topics and IESP symposia | ECE2015

X-linked acro-gigantism (X-LAG): a new form of infant-onset pituitary gigantism

Trivellin Giampaolo , Daly Adrian F. , Faucz Fabio R. , Yuan Bo , Rostomyan Liliya , Larco Darwin O. , Bjelobaba Ivana , Leal Leticia F. , Schernthaner-Reiter Marie Helene , Dimopoulos Aggeliki , Chittiboina Prashant , Choong Catherine S. , Kamenicky Peter , Wu T. John , Costanzi Stefano , Feldman Benjamin , Stojilkovic Stanko S. , Lupski James R. , Beckers Albert , Stratakis Constantine A.

Introduction: Pituitary gigantism is a rare disorder caused by GH-secreting lesions.Aim: We studied gigantism for genetic defects.Methods: We performed genome-wide analyses in 46 patients with gigantism and 248 patients with acromegaly.Results: We detected a novel microduplication at chromosome Xq26.3 in two unrelated kindreds and 13 sporadic cases de novo. All patients had disease onset before five ...

ea0063p383 | Thyroid 1 | ECE2019

Clinical presentation of patients with Autoimmune Polygranular Syndrome III (APS III)

Sapera Ageliki , Papadakis Georgios , Tampouratzi Dimitra , Kalaitzidou Styliani , Karavasili Chrysi , Kotis Michail , Aravantinou Ageliki , Roumpidaki Zoi , Dracopoulou Anna , Kaltzidou Victoria , Veniou Irini , Tertipi Athanasia

Background: The autoimmune polyglandular syndromes are clusters of endocrine abnormalities that occur in discreet patterns in subjects with immune dysregulation and that permit treatment and anticipation of associated systemic or other hormonal deficiencies. Three major entities are recognized, APS I, APS II and APS III. They are considered rare syndromes, but they are possibly not always thoroughly investigated. APS III, in contrast to APS I and II, does not involve the adren...

ea0063p678 | Pituitary and Neuroendocrinology 2 | ECE2019

Case report of pituitary adenoma with subclinical Cushing’s disease

Tampouratzi Dimitra , Kalaitzidou Styliani , Papadakis Georgios , Karavasili Chrysi , Kotis Michalis , Sapera Ageliki , Aravantinou Ageliki , Roumpidaki Zoi , Dracopoulou Anna , Kaltzidou Victoria , Tertipi Athanasia

Background: Subclinical Cushing disease is defined by mild hypercortisolism that results from a corticotroph pituitary adenoma, without any typical sign of the disease. The patients often have coexisting metabolic diseases such as diabetes mellitus, and hypertension. Conversely, silent corticotroph adenomas demonstrate normal cortisol secretion, but positive immunochemistry for ACTH, most usually without ACTH hypersecretion, although they and can progress to clinical Cushing d...

ea0049ep785 | Endocrine tumours and neoplasia | ECE2017

ER status heterogeneity in breast cancer: role in response to endocrine treatment

Gagliano Teresa , Ditsiou Angeliki , Grothey Arnhild , Giamas Georgios

Tumor heterogeneity affects diagnosis, prognosis and response to therapy. Heterogeneity is found in both normal and neoplastic human mammary gland. For example, luminal estrogen receptor (ER)-negative cells can give rise to various phenotypes, including ER-negative and ER-positive mammary tumors, suggesting that the cell-of-origin does not necessarily reflect the tumor type. Regarding ER status, heterogeneity can challenge endocrine therapies; elimination of responsive clones ...

ea0044ep96 | (1) | SFEBES2016

Acute confusion in a cyclist

Giannopoulou Angeliki , Hancock Sian , Kumar Senthil , Mallipedhi Akhila , Rice Sam

A 46-year-old male was brought to the hospital by his uncle as he was found to be acutely confused and agitated ‘talking rubbish’ and giggling inappropriately. Last time he was seen well was 3 days ago. He was a cyclist who lived alone and his past medical history included Graves’ disease and AF. He was on propranolol, carbimazole and warfarin. A month ago he needed admission to a different hospital after falling off his bike. At that time he also developed conf...

ea0056p654 | Endocrine tumours and neoplasia | ECE2018

Fibroblast-kinome silencing to identifies putative mediator of Triple-negative breast cancer (TNBC) invasion

Gagliano Teresa , Vella Viviana , Bienkowska Kamila , Ditsiou Angeliki , Giamas Georgios

Kinases represent a main therapeutic targets in cancer treatment as their impairing is related to tumor growth and progression. Despite the increasing evidence that tumor microenvironment (TME) signaling influences the behavior of surrounding cancer epithelial cells, still little is known about what changes in stromal cells influence tumor cells’ behavior. TNBC patients are still lacking an effective therapy, as not much is known about the biology of this BC tumor subtype...

ea0022p773 | Thyroid | ECE2010

Antenatal thyroid function and postpartum mood disturbances

Lambrinoudaki Irene , Rizos Demetrios , Armeni Eleni , Pliatsika Paraskevi , Leonardou Angeliki , Sygelou Angeliki , Argeitis John , Spentzou Georgia , Hasiakos Dimitrios , Zervas Ioannis , Papadias Constantinos

Background: Postpartum mood disturbances occur very often in otherwise healthy women, whereas thyroid function is affected during a normal pregnancy. We examined whether thyroid hormone levels in women free from thyroid dysfunction associate with the prevalence of postpartum mood disturbances.Methods: This cross-sectional study included 57 Greek women. Concentrations of thyroid hormones (free T3, free T4, TSH) and anti...

ea0081p308 | Calcium and Bone | ECE2022

The impact of age on quality of life and frailty outcomes after parathyroidectomy in patients with primary hyperparathyroidism

Papavramidis Theodosios S. , Anagnostis Panagiotis , Pliakos Ioannis , Tzikos Georgios , Chorti Angeliki , Kotsa Kalliopi , Michalopoulos Antonios

Objective: Parathyroidectomy (PTx) improves quality of life (QoL) in patients with primary hyperparathyroidism (PHPT). Whether this effect is modified according to the patients’ age is unknown. The aim of this study was to evaluate the impact of age on the effect of PTx on QoL and frailty in patients with PHPT, six months post-PTx. Methods: This was a prospective cohort study, including patients with PHPT, admitted from January 2016 to December 2019...

ea0063p38 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Influence of Tumor Microenviroment in response modulation to treatment in human BP-NENs

Bresciani Giulia , Ditsiou Angeliki , Cilibrasi Chiara , Vella Viviana , Giamas Georgios , Zatelli Maria Chiara , Gagliano Teresa

Introduction: Broncho-Pulmonary Neoplasms (BP-NENs) are rare neoplasms arising from neuroendocrine cells of the respiratory epithelium. Since previous studies in our lab have demonstrated the efficacy ofEverolimus, approved for BP-NENs treatment, and Dinaciclib, a Cyclins and CdKs inhibitor, on monolayer system we have investigated if a more complex tumour system could generate a change in drugs effects and cell resistance. Therefore, through the use of 3D culture model, we ha...